Whats Next for Vanda Pharmaceuticals VNDA at 646 20260514 Amneal AMRX Trading at 1235 Key Decision Point 20260514 Ares Capital ARCC Stock Today Unchanged at 1886 Key Levels 20260518 Massie Loses Primary Race After Betting Odds Favor Him at 78 on Kalshi US Consumer Sentiment Drops to Record Low in May as Gas Prices Surge Amid Iran Conflict US Payrolls Jump More Than Expected in April but Report Flags Economic Concerns Traders Bet on IonQ Micron Anduril as Next Potential Government Stake Targets Okta Sees AI Agents as Expanding IdentitySecurity Opportunity Amid Stock Weakness M1 Kliniken AG Completes Capital Reduction via Cancellation of Treasury Shares Jim Cramer Highlights Equinix as a Strategic Data Center Investment Play FTI Consulting FCN Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Uptick CSX Q1 2026 Earnings EPS Surprise Drives Profit Beat but Stock Declines Ernexa Therapeutics ERNA Q3 2023 Earnings ClinicalStage Biotech Reports Net Loss as Stock Declines FIGS Q1 2026 Earnings Strong EPS Beat Surprises Markets ATNI Q1 2026 Earnings Significant EPS Miss Reflects Operational Headwinds AnaptysBio Inc ANAB Q1 2026 Earnings Significant EPS Miss Amid Clinical Progress Axe Compute Inc AGPU Gains 168 as Stock Tests Key Resistance Zone Starry Sea Acquisition Corp SSEA Holds Steady Near Key Support Levels Amid Minimal Price Movement Liberty AllStar Equity Fund Edges Higher Amid Steady Trading One Liberty Properties OLP Edges Higher Modest Gain Amidst Sector Stability Powell Max Limited PMAX Declines 144 as Stock Tests Key Support Zone Gold Prices in 2026 Analysts Weigh Potential Rally Amid Global Uncertainty RDNT Q1 2026 Earnings EPS Misses Estimates by Wide Margin UBX Technology Ltd UBXG Surges 84 Breaking Above Key Support Level